Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (ADMET) | > 20 uM | Inhibition of human CYP3A4 assessed as terfenadine hydroxylation after 20 mins by LC-MS/MS analysis | ChEMBL. | 24900607 |
IC50 (ADMET) | > 20 uM | Inhibition of human CYP2D6 assessed as dextromethorphan O-demethylation after 20 mins by LC-MS/MS analysis | ChEMBL. | 24900607 |
IC50 (ADMET) | > 20 uM | Inhibition of human CYP2C9 assessed as tolbutamide hydroxylation after 20 mins by LC-MS/MS analysis | ChEMBL. | 24900607 |
IC50 (ADMET) | > 20 uM | Inhibition of human CYP1A2 assessed as ethoxyresorufin O-deethylation after 20 mins by fluorescence plate reader | ChEMBL. | 24900607 |
Inhibition (binding) | = 27.9 % | Inhibition of rat forebrain MAO-B using [14C]PEA as substrate at 30 uM preincubated for 20 mins followed by substrate addition measured after 10 mins by liquid scintillation counting analysis | ChEMBL. | 24900607 |
Inhibition (binding) | = 33.2 % | Inhibition of rat forebrain MAO-A using [14C]5-HT as substrate at 30 uM preincubated for 20 mins followed by substrate addition measured after 5 mins by liquid scintillation counting analysis | ChEMBL. | 24900607 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.